Flora Growth (NASDAQ:FLGC – Get Free Report) posted its quarterly earnings data on Monday. The company reported ($0.42) earnings per share for the quarter, missing the consensus estimate of ($0.11) by ($0.31), Zacks reports. Flora Growth had a negative return on equity of 268.17% and a negative net margin of 30.99%.
Flora Growth Trading Up 5.9 %
NASDAQ:FLGC traded up $0.04 on Monday, hitting $0.66. 91,166 shares of the stock were exchanged, compared to its average volume of 436,485. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.64 and a current ratio of 1.02. Flora Growth has a 52 week low of $0.59 and a 52 week high of $2.93. The company’s 50-day moving average price is $0.81 and its 200 day moving average price is $1.18.
Analyst Ratings Changes
Separately, Aegis started coverage on Flora Growth in a report on Monday, November 25th. They issued a “buy” rating and a $4.00 price target for the company.
About Flora Growth
Flora Growth Corp., together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products worldwide. It operates through three segments: House of Brands, Commercial and Wholesale, and Pharmaceuticals. The company cultivates, processes, and supplies medicinal-grade cannabis flower, and cannabis derived medical and wellness products.
Featured Stories
- Five stocks we like better than Flora Growth
- Short Selling: How to Short a Stock
- Super Micro Stock: $7.2M Call Options Signal Big Upside Potential
- Golden Cross Stocks: Pattern, Examples and Charts
- Top 3 Buy-and-Hold Stocks for 2025: Long-Term Winners to Watch
- The How And Why of Investing in Oil Stocks
- D-Wave Stock: Is Quantum Blockchain the Next Big Catalyst?
Receive News & Ratings for Flora Growth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Flora Growth and related companies with MarketBeat.com's FREE daily email newsletter.
